For much of lance Armstrong PDF second phase of his career, American cyclist Lance Armstrong faced constant allegations of doping. If you consider my situation: a guy who comes back from arguably, you know, a death sentence , why would I then enter into a sport and dope myself up and risk my life again? Armstrong has been criticized for his disagreements with outspoken opponents of doping such as journalist Paul Kimmage and cyclist Christophe Bassons. Kimmage, a professional cyclist in the 1980s who later became a sports journalist, referred to Armstrong as a « cancer in cycling ».
Lorsque Lance Armstrong abandonne le Tour de France en 1996, les observateurs ne poussent pas plus loin les investigations. Le coureur Motorola, lui aussi, se persuade que tout cela n’est que passager mais dans la foulée, de retour des J0, où il n’est pas en mesure de se battre pour la médaille, son corps lui envoie un nouveau signal de fatigue. Persuadé qu’il s’agit à nouveau d’une mauvaise grippe, Armstrong passe beaucoup d’heures au lit, espérant se requinquer. La douleur le rattrape le 20 septembre 1996, alors qu’il assiste à un concert avec des amis. Une douleur crânienne insupportable qu’aucun cachet ne peut atténuer. Puis, quelques jours plus tard, après une quinte de toux, du sang qui sort de sa bouche. Enfin, encore cette douleur aux testicules alors qu’il enfourche son scooter pour aller faire des courses, suivie d’une nouvelle inflammation. Autant de signes qui le poussent à consulter malgré lui. Et là, il apprend la terrible nouvelle à l’issue d’une batterie d’examens radiologiques. Son mal porte un nom : cancer des testicules, avec développement rapide de métastases. A cet instant, étrangement, il n’a pas pensé immédiatement qu’il allait mourir. Non, il s’est dit : » Je ne pourrais plus jamais courir ! » Seulement, une fois seul, après être revenu chez lui, il s’est mis à pleurer et a pris conscience que sa vie était en jeu. Lui qui croyait connaître la peur en découvre le vrai sens ce jour-là. Elle va l’accompagner durant trois mois d’incertitudes, jalonnés d’opérations et de traitements de chimiothérapie. Au bout du compte, ces passages sont uniques dans une vie et sans doute pour cette raison que l’Américain ose parler de chance lorsqu’il évoque cette période. Sans le soutien de ses proches, il avoue qu’il aurait sans doute déprimé, voire laissé tombé… » C’est un combat pour ma vie, et j’ai l’intention de le gagner « . Il le gagnera, avant de dévorer la vie et la Grande Boucle à pleines dents.
Until his 2013 admission, Armstrong continually denied using illegal performance-enhancing drugs and described himself as the most tested athlete in the world. From his return to cycling in the fall of 2008 through March 2009, Armstrong submitted to twenty-four unannounced drug tests by various anti-doping authorities. All of the tests were negative for performance-enhancing drugs. Armstrong faced accusations of doping as early as the 1999 Tour de France. Specifically, many European papers contended his victory in Stage 9, where he seemingly ascended the Alps with almost no difficulty, could not have been possible through natural means.
Armstrong adamantly denied this, and the American press generally supported him. Armstrong was criticized for working with controversial Italian trainer Michele Ferrari, who later claimed that the two were introduced by Belgian cyclist Eddy Merckx in 1995. Ferrari was later absolved of all charges by an Italian appeals court of the sporting fraud charges as well as charges of abusing his medical license to write prescriptions. The court stated that it overturned his conviction « because the facts do not exist » to support the charges.
In 2004, Walsh and fellow reporter Pierre Ballester published a French-language book alleging Armstrong had used performance-enhancing drugs, entitled L. Allegations in the book were reprinted in The Sunday Times in a story by deputy sports editor Alan English in June 2004. On March 31, 2005, Mike Anderson, Armstrong’s personal assistant of two years, filed a brief in Travis County District Court in Texas, as part of a legal battle following his termination in November 2004. In June 2006, the French newspaper Le Monde reported claims by Frankie and Betsy Andreu during a deposition that Armstrong had admitted using performance-enhancing drugs to his physician just after brain surgery in 1996.
Armstrong suggested Betsy may have been confused by possible mention of his post-operative treatment, which included steroids and EPO that are taken to counteract the side effects of intensive chemotherapy. In July 2006, the Los Angeles Times published a story on the allegations raised in the SCA case. The report cited evidence at the trial, including the results of an AFLD test and an analysis of these results by an expert witness. SCA president Bob Hamman knew his chances of winning the suit were slim, since the language in SCA’s contract with Armstrong stipulated that the money had to be paid. However, he believed that the testimony and evidence would prove that Armstrong was a doper, and would be enough to trigger an investigation by sporting authorities. Ashenden’s findings were disputed by the Vrijman report, which pointed to procedural and privacy issues in dismissing the AFLD test results.